Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05799872 · ClinicalTrials.gov registry record · NA

Neuroscience-informed Treatment to Remotely Target Reward Mechanisms in Post-acute Anorexia Nervosa

A NA study of Anorexia Nervosa, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05799872 is a NA study of Anorexia Nervosa that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 90 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05799872, a NA study of Anorexia Nervosa, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The investigators will recruit individuals with broadly-defined AN (n = 80) who are currently in or have recently participated in higher-level eating disorder treatment (e.g., residential, partial hospitalization/day treatment, intensive outpatient treatment). Interested participants will sign consent, complete eligibility assessments, and will be randomized to receive Positive Affect Treatment for Anorexia Nervosa (PAT-AN) or Psychoeducation and Behavioral Therapy (PBT) through teletherapy shortly following discharge from higher level of care. Participants can participate in most other forms of outpatient treatment while receiving the research intervention. Participants will engage in 24 weeks of PAT-AN or PBT starting in the first 3 months post-discharge. At each session, the investigators will complete brief measures assessing treatment acceptability, affect, and eating disorder symptoms. Participants will also complete an assessment battery of self-report, EMA, and neurocognitive measures evaluating primary outcomes (BMI; eating disorder symptoms), secondary outcomes (depression, anxiety, and suicidality), and presumed treatment mechanisms at baseline, end of treatment (EOT), and 3-month follow-up (FU). All assessments will be remotely delivered via HIPAA-compliant platforms.

Conditions Studied

Interventions

  • BEHAVIORAL Positive Affect Treatment for Anorexia Nervosa (PAT-AN):
  • BEHAVIORAL Psychoeducational and Behavioral Therapy (PBT)

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-12-06
Est. Completion 2026-10-30
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05799872

The ClinicalTrials.gov registry entry for NCT05799872 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Positive Affect Treatment for Anorexia Nervosa (PAT-AN): is the first listed.

NCT05799872 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05799872 about?

NCT05799872 is a clinical study titled "Neuroscience-informed Treatment to Remotely Target Reward Mechanisms in Post-acute Anorexia Nervosa". The investigators will recruit individuals with broadly-defined AN (n = 80) who are currently in or have recently participated in higher-level eating disorder treatment (e.g., residential, partial hospitalization/day treatment, intensive outpatient treatment). Interested participants will sign conse...

What is the current status of trial NCT05799872?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-12-06. Estimated completion is 2026-10-30.

What conditions does trial NCT05799872 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT05799872?

The interventions under investigation include: Positive Affect Treatment for Anorexia Nervosa (PAT-AN): (BEHAVIORAL), Psychoeducational and Behavioral Therapy (PBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05799872?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05799872 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.